Related Experiment Videos
Inhaled nitric oxide during emergency neonatal transportation
1Department of Intensive Care, Royal Alexandra Hospital for Children, Westmead, Australia.
Journal of Paediatrics and Child Health
|December 1, 1996
Summary
Continuous inhaled nitric oxide (iNO) safely transported critically ill neonates with persistent pulmonary hypertension. This method supports high-level intensive care during emergency retrieval, improving outcomes for neonates requiring advanced respiratory support.
Area of Science:
- Neonatology
- Pediatric Critical Care
- Pulmonary Medicine
Background:
- Persistent pulmonary hypertension of the neonate (PPHN) is a critical condition requiring specialized care.
- Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator used for PPHN treatment.
- Emergency transportation of critically ill neonates presents unique challenges for maintaining advanced therapies.
Observation:
- This study describes the use of continuous iNO during emergency retrieval of three neonates with meconium aspiration and PPHN.
- The neonates required high-level intensive care, including high-frequency ventilation and/or extracorporeal life support.
Findings:
- Continuous iNO administration was successfully applied during emergency transportation.
- The technique facilitated the safe transfer of critically ill neonates requiring ongoing advanced respiratory support.
Implications:
- This approach may enable safer transportation for neonates with PPHN and other critical conditions.
- Centralizing iNO resources via specialized retrieval teams can enhance expertise and research opportunities.
- It may alleviate the burden on smaller neonatal intensive care units, allowing for better resource allocation and specialized care delivery.